Teva Pharmaceutical Industries
FDA Approves Truxima, First Biosimilar to Rituxan
Truxima can be used to treat three types of adults with non-Hodgkin lymphoma.
NOVEMBER 29, 2018
Teva Launches Generic Version of Reyataz
Generic atazanavir sulfate capsules are a protease inhibitor (PI) used in combination with other ART for the ...
DECEMBER 28, 2017
Load more